胶质瘤结局的社会经济差异:按级别的分析
这项回顾性队列研究分析了199例在英国接受胶质瘤切除术的成人患者,按贫困指数(IMD)五分位分层,发现IMD五分位与任何级别胶质瘤的总生存无关;但在4级胶质瘤中,较高社会经济地位与更长的无进展生存相关(每五分位HR 0.72,95%CI 0.55–0.94,p=0.017)。围手术期并发症、再手术率和功能下降未见差异。
要点
- 社会经济贫困与胶质母细胞瘤更早进展相关,校正预后因素和切除程度后仍显著。
- 4级胶质瘤中,社会经济地位每提高一个五分位,进展风险降低28%。
- 2级和3级胶质瘤中未观察到社会经济地位与生存的关联。
核心结论
- 社会经济贫困与胶质母细胞瘤切除后更早的疾病进展相关,校正年龄、分子标志物和术前功能状态后关联仍存在。
- 围手术期结局和治疗开始未见社会经济差异,提示不平等可能出现在纵向肿瘤治疗过程中而非手术治疗本身。
研究设计与样本
- 回顾性队列研究,纳入2010至2024年间在英国某三级神经外科中心接受手术切除的199例WHO 2–4级胶质瘤成人患者。
- 按贫困指数(IMD)五分位分层,主要结局为总生存(OS)和无进展生存(PFS),采用多变量Cox回归校正年龄、IDH突变、MGMT甲基化和术前功能状态。
主要发现
- 切除程度和接受辅助治疗在各IMD五分位间无显著差异(切除程度p=0.123)。
- IMD五分位与任何级别的总生存均无关联。
- 4级胶质瘤(n=122;完整病例分析n=88)中,较高社会经济地位与更长无进展生存相关(每五分位HR 0.72,95%CI 0.55–0.94,p=0.017),即每五分位进展风险降低28%。
- 2级或3级肿瘤中未观察到关联,围手术期并发症、再手术率或功能下降也未见关联。
临床怎么用
- 神经肿瘤随访路径中应关注社会经济弱势的胶质母细胞瘤患者,其疾病进展风险可能更高。
- 围手术期治疗和辅助治疗启动未见差异,提示干预重点可放在纵向肿瘤治疗的可及性与支持上。
局限性
- 回顾性单中心设计,样本量有限(4级完整病例分析仅88例)。
- 社会经济地位采用区域层面贫困指数,非个体层面数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Socioeconomic deprivation influences outcomes across numerous neurosurgical conditions, yet its impact on glioma remains poorly characterised. This study examined whether area-level deprivation, measured by the Index of Multiple Deprivation (IMD), was associated with survival and perioperative outcomes following glioma resection. METHODS: This retrospective cohort study analysed 199 adults undergoing surgical resection for WHO Grade 2–4 gliomas at a UK tertiary neurosurgical centre between 2010 and 2024. Patients were stratified by IMD quintile. Primary outcomes were overall survival (OS) and progression-free survival (PFS). Multivariable Cox regression models adjusted for age, molecular markers (IDH mutation, MGMT methylation), and preoperative functional status, with separate analyses by tumour grade. RESULTS: Extent of resection and receipt of adjuvant therapy did not differ significantly across IMD quintiles (extent of resection p = 0.123). IMD quintile was not associated with OS in any grade. However, in Grade 4 gliomas (n = 122; n = 88 for complete case analysis), higher socioeconomic status was associated with longer PFS (HR 0.72 per quintile increase, 95% CI 0.55–0.94, p = 0.017), representing a 28% reduction in progression risk per quintile. No associations were observed for Grade 2 or 3 tumours, nor for perioperative complications, reoperation rates, or functional decline. CONCLUSIONS: Socioeconomic deprivation was associated with earlier disease progression in glioblastoma following adjustment for established prognostic factors and extent of resection. The absence of perioperative disparities and equitable treatment initiation suggests inequalities emerge during longitudinal oncological care rather than surgical treatment. These findings highlight the need for healthcare systems to address socioeconomic barriers in neuro-oncology pathways.
引用
- Hon JJ, Akbarzadeh Mostaghbal H, Akkara Y, et al. Socioeconomic disparities in glioma outcomes: a grade-specific analysis. J Neurooncol. 2026. PMID: 41632383. doi:10.1007/s11060-026-05436-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。